Creative Medical Technology Holdings, Inc.

CELZ ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Cash Flow Statement
Annual Quarterly

Cash Flow Statement

Line Item FY2017 FY2016 FY2015 FY2014 FY2013 FY2012 FY2011 FY2010
Operating Activities
Net Income $-2.7M $-766.1K $-30.8K $-28.0K $-27.3K $-25.6K $-24.1K $-17.3K
Depreciation & Amortization
Depreciation
Amortization $16.0K $9.4K
Stock-Based Compensation $144.2K $2.6K
Net Cash from Operating Activities $-889.6K $-445.2K $-14.6K $-17.3K $-22.9K $-16.8K $-14.0K $-13.7K
Investing Activities
Capital Expenditures
Business Acquisitions
Net Cash from Investing Activities $0 $-10.0K $0 $0 $0 $0 $0 $0
Financing Activities
Dividends Paid
Stock Repurchases
Net Cash from Financing Activities $681.5K $677.0K $13.9K $17.9K $22.5K $16.5K $14.7K $13.5K
Net Change in Cash $-208.2K $221.8K $-738 $580 $-407 $-324 $691 $-161
Free Cash Flow
← Newer Page 2 of 2 Older →